SPI009's chemical name is 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol.

What kind of treatment would use this (oral ingestion? intravenous therapy?), and how might someone get this on the market?

Here is some literature https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809444/

This would (in US) undergo drug approval process via NDA based on safety and efficacy.    Appears the molecule is owned by Center for Drug Design and Discovery - I don;t see SPI009 mentioned on their website http://www.cd3.eu/- .